Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLF
|
AU |
|
Falco Resources Ltd
XTSX:FPC
|
CA |
|
Larsen & Toubro Infotech Ltd
NSE:LTI
|
IN |
|
Conart Engineers Ltd
BSE:522231
|
IN |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
|
W
|
Willowglen Msc Bhd
KLSE:WILLOW
|
MY |
|
Remy Cointreau SA
PAR:RCO
|
FR |
|
F
|
Finbond Group Ltd
JSE:FGL
|
ZA |
Wall St Price Targets
CLVLF Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for CLVLF is 15.15 USD with a low forecast of 6.92 USD and a high forecast of 30.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLVLF's stock price target?
Price Target
15.15
USD
According to Wall Street analysts, the average 1-year price target for CLVLF is 15.15 USD with a low forecast of 6.92 USD and a high forecast of 30.85 USD.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%
The compound annual growth rate for Gross Profit over the next 8 years is 8%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
12%
The compound annual growth rate for Pre-Tax Income over the next 4 years is 12%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
11%
The compound annual growth rate for Net Income over the next 8 years is 11%.
